Lido Advisors’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-6,887
| Closed | -$207K | – | 1040 |
|
|
2023
Q1 | $207K | Buy |
6,887
+120
| +2% | +$3.61K | ﹤0.01% | 903 |
|
|
2022
Q4 | $191K | Sell |
6,767
-122,655
| -95% | -$3.46M | ﹤0.01% | 802 |
|
|
2022
Q3 | $4.25M | Sell |
129,422
-27,799
| -18% | -$914K | 0.05% | 149 |
|
|
2022
Q2 | $4.95M | Sell |
157,221
-3,190
| -2% | -$100K | 0.07% | 123 |
|
|
2022
Q1 | $7.37M | Buy |
160,411
+41,056
| +34% | +$1.89M | 0.08% | 105 |
|
|
2021
Q4 | $7.42M | Buy |
119,355
+20,689
| +21% | +$1.29M | 0.08% | 115 |
|
|
2021
Q3 | $7.37M | Buy |
98,666
+13,387
| +16% | +$1M | 0.1% | 96 |
|
|
2021
Q2 | $7.89M | Buy |
85,279
+32,763
| +62% | +$3.03M | 0.11% | 96 |
|
|
2021
Q1 | $4.66M | Buy |
52,516
+11,375
| +28% | +$1.01M | 0.08% | 127 |
|
|
2020
Q4 | $3.84M | Buy |
41,141
+18,581
| +82% | +$1.73M | 0.08% | 128 |
|
|
2020
Q3 | $1.44M | Buy |
22,560
+9,036
| +67% | +$576K | 0.04% | 185 |
|
|
2020
Q2 | $705K | Buy |
13,524
+1,353
| +11% | +$70.5K | 0.02% | 257 |
|
|
2020
Q1 | $381K | Buy |
12,171
+6,163
| +103% | +$193K | 0.02% | 340 |
|
|
2019
Q4 | $201K | Buy |
+6,008
| New | +$201K | 0.01% | 556 |
|